Notice 8 Jul 2025 nasa, aerospace, intellectual property, patent licensing, exclusive rights

🚀NASA's Notice of Intent to Grant Exclusive Patent Licenses

NASA hereby gives notice of its intent to grant an exclusive, co-exclusive or partially exclusive patent license to practice the inventions described and claimed in the patents and/or patent applications listed in SUPPLEMENTARY INFORMATION below.

Learn More
Notice 8 Jul 2025 technology, nasa, business implications, innovation, intellectual property, patent licensing

🚀NASA's Notice to Grant Patent License

NASA hereby gives notice of its intent to grant an exclusive, co-exclusive or partially exclusive patent license to practice the inventions described and claimed in the patents and/or patent applications listed in SUPPLEMENTARY INFORMATION below.

Learn More
Notice 3 Jul 2025 healthcare, investment, nih, technology transfer, patent licensing, autoimmune diseases, commercial opportunities, biopharma

💊Exclusive Patent License Notice for CAR Technology by NIH

The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patents applications listed in the Supplementary Information section of this notice to Capstan Therapeutics, Inc. (Capstan), a company located in San Diego, California, the United States of America.

Learn More
Notice 2 Jul 2025 grants, health, research, biotechnology, patent licensing, immune response

🦠Exclusive License Opportunity for Engineered Commensal Bacteria Technology

The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive, Inter- Institutional Agreement-Institution Lead to CZ Biohub SF, LLC ("CZB"), located in San Francisco, California, in its rights to the technologies and patent applications listed in the Supplementary Information section of this notice.

Learn More
Notice 17 Jun 2025 nasa, intellectual property, patent licensing, bayh-dole act, exclusive rights, vedphoto

📄NASA Notice

NASA hereby gives notice of its intent to grant an exclusive, co-exclusive or partially exclusive patent license to practice the inventions described and claimed in the patents and/or patent applications listed in SUPPLEMENTARY INFORMATION below.

Learn More
Notice 17 Jun 2025 federal regulations, nasa, innovation, technology transfer, patent licensing

🛠️NASA's Intent to Grant Exclusive Patent Licenses

NASA hereby gives notice of its intent to grant an exclusive, co-exclusive or partially exclusive patent license to practice the inventions described and claimed in the patents and/or patent applications listed in SUPPLEMENTARY INFORMATION below.

Learn More
Notice 18 Jun 2025 defense contracting, business regulation, technology, air force, intellectual property, patent licensing

📑Exclusive Patent License Notice for Intuidex, Inc.

Pursuant to the Bayh-Dole Act and implementing regulations, the Department of the Air Force hereby gives notice of its intent to grant an exclusive patent license to Intuidex, Inc. duly organized, validly existing, and in good standing in the State of Wyoming having a place of business at 1892 Mill Run CT, Hellertown, PA 18055.

Learn More
Notice 2 Jun 2025 pharmaceuticals, health, patent licensing, biotech, cns disorders

💊Exclusive Patent License for CNS Therapeutics by NIH

The National Institute of Neurological Disorders and Stroke and the National Center for Advancing Translational Sciences, institutes of the National Institutes of Health, Department of Health and Human Services, are contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this Notice to Psycala Bio, Inc. (Psycala), incorporated in Delaware.

Learn More
Notice 17 Apr 2025 nih, biomedical, technology transfer, patent licensing, electroporation, cambridge enterprise, health innovation

🧬Exclusive Patent License Opportunity for Biomedical Innovations

The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable patent license to Cambridge Enterprise Limited, University of Cambridge, located in Cambridge, United Kingdom, to practice the inventions embodied in the patent applications listed in the Supplementary Information section of this notice.

Learn More
Notice 14 Mar 2025 technology, nasa, business opportunities, innovation, patent licensing

🚀NASA Notice

NASA hereby gives notice of its intent to grant an exclusive, co-exclusive or partially exclusive patent license to practice the inventions described and claimed in the patents and/or patent applications listed in SUPPLEMENTARY INFORMATION below.

Learn More